44 related articles for article (PubMed ID: 31397184)
1. Comparative efficacy of combination bronchodilator therapies in COPD: a network meta-analysis.
Huisman EL; Cockle SM; Ismaila AS; Karabis A; Punekar YS
Int J Chron Obstruct Pulmon Dis; 2015; 10():1863-81. PubMed ID: 26392761
[TBL] [Abstract][Full Text] [Related]
2. A dose-ranging study of tiotropium delivered via Respimat Soft Mist Inhaler or HandiHaler in COPD patients.
Caillaud D; Le Merre C; Martinat Y; Aguilaniu B; Pavia D
Int J Chron Obstruct Pulmon Dis; 2007; 2(4):559-65. PubMed ID: 18268929
[TBL] [Abstract][Full Text] [Related]
3. Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial.
Troosters T; Sciurba FC; Decramer M; Siafakas NM; Klioze SS; Sutradhar SC; Weisman IM; Yunis C
NPJ Prim Care Respir Med; 2014 May; 24():14003. PubMed ID: 24841833
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease.
Hohlfeld JM; Sharma A; van Noord JA; Cornelissen PJ; Derom E; Towse L; Peterkin V; Disse B
J Clin Pharmacol; 2014 Apr; 54(4):405-14. PubMed ID: 24165906
[TBL] [Abstract][Full Text] [Related]
5. The 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2-4 COPD: results from two 6-week crossover studies.
Feldman GJ; Bernstein JA; Hamilton A; Nivens MC; Korducki L; LaForce C
Springerplus; 2014; 3():419. PubMed ID: 25187881
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium Bromide Attenuates Mucus Hypersecretion in Patients with Stable Chronic Obstructive Pulmonary Disease.
Yu S; Zhang C; Yan Z; Fang Q; Gao X
Comput Math Methods Med; 2021; 2021():1341644. PubMed ID: 34650619
[TBL] [Abstract][Full Text] [Related]
7. Short Term Effects of Tiotropium on COPD Patients Treated with Long Acting Bronchodilators.
Nicolini A
Tanaffos; 2012; 11(1):26-31. PubMed ID: 25191397
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Effect of Different Airflow Rates on the Aerosol Properties of Nebulized Glycopyrrolate in the eFlow® Closed System and Tiotropium Delivered in the HandiHaler®.
Ohar JA; Bauer A; Sharma S; Sanjar S
Pulm Ther; 2020 Dec; 6(2):289-301. PubMed ID: 32809156
[TBL] [Abstract][Full Text] [Related]
9. Randomized Trial of Nocturnal Oxygen in Chronic Obstructive Pulmonary Disease.
Lacasse Y; Sériès F; Corbeil F; Baltzan M; Paradis B; Simão P; Abad Fernández A; Esteban C; Guimarães M; Bourbeau J; Aaron SD; Bernard S; Maltais F;
N Engl J Med; 2020 Sep; 383(12):1129-1138. PubMed ID: 32937046
[TBL] [Abstract][Full Text] [Related]
10. Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Rabe KF; Martinez FJ; Ferguson GT; Wang C; Singh D; Wedzicha JA; Trivedi R; St Rose E; Ballal S; McLaren J; Darken P; Aurivillius M; Reisner C; Dorinsky P;
N Engl J Med; 2020 Jul; 383(1):35-48. PubMed ID: 32579807
[TBL] [Abstract][Full Text] [Related]
11. The pharmacogenomics of inhaled corticosteroids and lung function decline in COPD.
Obeidat M; Faiz A; Li X; van den Berge M; Hansel NN; Joubert P; Hao K; Brandsma CA; Rafaels N; Mathias R; Ruczinski I; Beaty TH; Barnes KC; Man SFP; Paré PD; Sin DD
Eur Respir J; 2019 Dec; 54(6):. PubMed ID: 31537701
[TBL] [Abstract][Full Text] [Related]
12. Home initiation of chronic non-invasive ventilation in COPD patients with chronic hypercapnic respiratory failure: a randomised controlled trial.
Duiverman ML; Vonk JM; Bladder G; van Melle JP; Nieuwenhuis J; Hazenberg A; Kerstjens HAM; van Boven JFM; Wijkstra PJ
Thorax; 2020 Mar; 75(3):244-252. PubMed ID: 31484786
[TBL] [Abstract][Full Text] [Related]
13. Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial.
Slebos DJ; Shah PL; Herth FJF; Pison C; Schumann C; Hübner RH; Bonta PI; Kessler R; Gesierich W; Darwiche K; Lamprecht B; Perez T; Skowasch D; Deslee G; Marceau A; Sciurba FC; Gosens R; Hartman JE; Srikanthan K; Duller M; Valipour A;
Am J Respir Crit Care Med; 2019 Dec; 200(12):1477-1486. PubMed ID: 31404499
[No Abstract] [Full Text] [Related]
14. Bronchodilator efficacy of tiotropium/formoterol (18/12 µg once daily via a Discair inhaler), tiotropium alone (18 µg by Handihaler) or combined with formoterol (12 µg twice daily by Aerolizer) in adults with moderate-to-severe stable COPD.
Yildiz BP; Bayraktaroglu M; Gunen H
Curr Med Res Opin; 2019 Dec; 35(12):2187-2196. PubMed ID: 31397184
[No Abstract] [Full Text] [Related]
15. Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair
Yildiz P; Bayraktaroglu M; Gorgun D; Secik F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2859-2867. PubMed ID: 27920513
[TBL] [Abstract][Full Text] [Related]
16. AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD.
Sethi S; Kerwin E; Watz H; Ferguson GT; Mroz RM; Segarra R; Molins E; Jarreta D; Garcia Gil E
Int J Chron Obstruct Pulmon Dis; 2019; 14():667-682. PubMed ID: 30962681
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study.
Buhl R; Gessner C; Schuermann W; Foerster K; Sieder C; Hiltl S; Korn S
Thorax; 2015 Apr; 70(4):311-9. PubMed ID: 25677679
[TBL] [Abstract][Full Text] [Related]
18. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.
Keam SJ; Keating GM
Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Aclidinium/Formoterol versus Tiotropium in COPD: Results of an Indirect Treatment Comparison.
Medic G; Lindner L; van der Weijden M; Karabis A
Adv Ther; 2016 Mar; 33(3):379-99. PubMed ID: 26883661
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
